Intelligent Bio Solutions
INBS
8 hedge funds and large institutions have $347K invested in Intelligent Bio Solutions in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding
Funds holding: 8 → 8 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
60% less capital invested
Capital invested by funds: $868K → $347K (-$521K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$45.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$32.1K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.59K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$273K |
| 2 |
Bank of New York Mellon
New York
|
-$78K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$50.5K |
| 4 |
Morgan Stanley
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $107K | -$50.5K | -11 | -26% |
|
|
WP
2
WealthShield Partners
Cary,
North Carolina
| $71K | – | – | – |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $56K | +$27.6K | +6 | +60% |
|
|
4
Jane Street
New York
| $36K | +$45.9K | +10 | New |
|
5
BlackRock
New York
| $32K | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| $24K | +$32.1K | +7 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $13K | +$4.59K | +1 | +33% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $8K | +$4.59K | +1 | +100% |
|
|
9
Geode Capital Management
Boston,
Massachusetts
| – | -$273K | -45 | Closed |
|
|
10
Bank of New York Mellon
New York
| – | -$78K | -13 | Closed |
|
|
11
Morgan Stanley
New York
| – | -$1K | – | – |
|
INBS Hedge Fund Activity: Q4 2021 in Review
8 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q4 2021, worth a combined $347K — down 60% from $868K a quarter earlier.
Fund positioning in INBS was balanced in Q4 2021: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $45.9K. The largest seller was Geode Capital Management, exiting entirely with an estimated $273K sold.
- 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $347K of Intelligent Bio Solutions stock for Q4 2021, down 60% quarter-over-quarter.
- 2 funds opened new Intelligent Bio Solutions positions in Q4 2021 and 2 closed out, a net change of 0 holders.
- The largest Intelligent Bio Solutions buyer in Q4 2021 was Jane Street, an estimated $45.9K added.
- The largest Intelligent Bio Solutions seller in Q4 2021 was Geode Capital Management, an estimated $273K sold.
Based on aggregated 13F filings for Q4 2021.